Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 70771-1087

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 70771-1087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8dac3a07 3405 4161 Aeaf 0b383d5a2ef9 07

This is a medication description for Oxybutynin Chloride Extended-Release Tablets. The tablets are coated and meant to be swallowed whole. They should be kept dry and stored at controlled room temperature. It's important to keep this medication away from children. The manufacturer is Zydus and the packaging contains 30 tablets.*

FDA Label Image

8dac3a07 3405 4161 Aeaf 0b383d5a2ef9 08

This is a medication description for Oxybutynin Chloride Extended-Release tablets in a 10mg dosage with 30 tablets per bottle. The tablets are coated and manufactured by a company called Zydus. No further information is available.*

FDA Label Image

8dac3a07 3405 4161 Aeaf 0b383d5a2ef9 09

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.